The OSU Division of Infectious Diseases engages in a wide spectrum of clinical and basic research sponsored by the pharmaceutical industry. These include Phase 1 to 3 clinical trials of anti-infective agents and vaccines.
Use of these agents, which are not yet marketed, gives both patients and investigators exposure to "medicine of the future". Such therapeutic or pharmacologic studies are selected to meet patient and investigator needs and research interests.
Recent pharmaceutical industry-supported trials include:
Michael F. Para, MD
Professor of Internal Medicine and Molecular
Virology, Immunology, and Medical Genetics
N. 1143 Doan Hall
410 W. 10th Avenue
Columbus, Ohio 43210
Phone: (614) 293-5666